GMP consulting for biotech, CDMOs, and biopharma.

We are not a consultancy chasing billable hours.
And we are definitely not recruiters sending you CVs we barely understand.

When you contact us, we do not ask how many hours you need.
We ask what problem you need to solve.

We do not offer junior consultants learning on your time.
We do not leave you to screen candidates because we lack the technical expertise to filter them.

Instead, we listen.
We understand your challenge.
And we know — often from the first call — who is the right expert or team to solve it.

Because at GMP Bridge, we work like we did before consultancy:
We listen to understand. We move things forward. We make sure the problem gets solved. Then we get out of the way. 

That is why clients trust us.

We have spent our careers inside biotech facilities, CDMO operations, and aseptic production plants.

Now, we help other companies avoid the mistakes we have seen… and solve the ones already happening.

From clinical-stage biotech and Cell & Gene Therapy developers to commercial biopharma manufacturers, we work where medicines are actually made.

Because when GMP becomes a business problem, you do not need frameworks.
You need solutions. Delivered by people who have solved it before.

That is who we are. That is GMP Bridge.

We are not building a consultancy.
We are building a trusted inner circle of people who get things done.

That is why senior consultants choose us.

Because we only work with people we trust — technically, and personally.
Because we do not manage “pools of candidates”.
Because we know that the right expert is the one who has solved the problem before — not the one who is available next week.

And because we work differently:

Our consultants are freelancers.
And we respect — even honour — that freedom.
We do not lock people into exclusivity agreements.
If you build trust with a client, we will never block future work with them.
Relationships are earned — not restricted.

When consultants join GMP Bridge, they know:

They work alongside other senior professionals.
They are called when experience matters — not to fill a timesheet.
They solve real problems for real clients.
And they have a team behind them — not just a contract.

Because GMP Bridge is more than a network.
It is a team.
A group of senior experts who meet regularly, share insights, and learn from each other.

And when the project is done, they know something rare:

They delivered something that mattered.
And they did it with the freedom they chose — but never alone.

• Because we execute. Every project is led by someone who has solved the problem before.
• Because we simplify. GMP is not about bureaucracy — it is about control. We help you focus on what actually matters.
• Because we do not overpromise. We do not sell abstract solutions. We solve the problem that blocks you.
• Because we bridge gaps. Between Quality and Operations. Between CDMOs and their clients. Between leadership teams and frontline execution.
• Because we think like partners — not like consultants. When you explain your challenge, we know who you need. And we focus on solving it as effectively as possible — not on maximizing billable hours.
   

• Inspections passed.
  FDA, EMA, Swissmedic — when regulators arrive, your site and your people are ready.
   
• CDMOs under control.
  We help you manage and recover control over external manufacturing before it threatens your supply chain.
   
• Sterility risks eliminated.
  For biopharma manufacturers, we strengthen sterility assurance, contamination control, and Annex 1 compliance where it matters most: in production.
   
• Quality systems that work.
  We design lean, scalable Quality Systems — not paperwork factories.
   
• Bottlenecks cleared.
  From batch release delays to deviation backlogs, we fix what’s slowing you down.
   
• GMP that supports business.
  We align compliance, supply, and growth — turning GMP from a cost center into a competitive advantage.
   

Because if "compliance" has become the excuse for why your company is not moving forward — maybe it is time we talked.